
Prostate cancer treatment involves a range of clinical interventions aimed at managing or eliminating malignant cells within the prostate gland. Modern treatment focuses on high-precision oncology, utilizing robotic surgery and targeted radioligand therapies to address tumors while preserving urinary and reproductive function. This ensures a personalized approach based on the specific aggressiveness of the disease.
Increased Urinary Frequency: Particularly noticing the need to urinate more often during the night (nocturia).
Weak or Interrupted Flow: Noticing a hesitant, weak, or frequently interrupted urine stream.
Difficulty Starting: Struggling to start or maintain a consistent stream of urination.
Hematuria or Hematospermia: The presence of blood in the urine or the seminal fluid.
Discomfort: Persistent pain or a burning sensation during urination or ejaculation.
Chronic Pain: Persistent discomfort in the lower back, hips, or pelvic region that does not resolve with rest.
Adenocarcinoma: Confirmed prostate cancer often initially identified through elevated PSA (Prostate-Specific Antigen) levels.
High-Risk Tumors: Aggressive disease characterized by a high Gleason score (8–10).
Metastatic Disease: Cancer that has migrated beyond the gland to the bones or pelvic lymph nodes.
Recurrent Cancer: Cases where PSA levels begin to rise following initial surgical or radiation interventions.
Genetic Predispositions: Patients with inherited mutations such as BRCA1, BRCA2, or HOXB13, which may require specialized precision therapies.
Mapping: Multiparametric MRI (mpMRI) is utilized to visualize and map suspicious areas within the gland with high anatomical detail.
Biopsy: A targeted biopsy is conducted to confirm the presence of malignant cells and determine the precise grade of the tumor.
Robotic Surgery: A robotic-assisted radical prostatectomy is performed to remove the prostate gland with sub-millimeter precision, protecting adjacent nerves.
Hormonal Control: Androgen Deprivation Therapy (ADT) is administered via medication to reduce the testosterone levels fueling the cancer's growth.
Radioligand Therapy: Advanced systemic agents are introduced to the bloodstream to deliver radiation directly to cells expressing specific proteins like PSMA.
Monitoring: Regular follow-up testing of PSA levels is conducted to monitor the success of the treatment and ensure continued remission.
Robotic-Assisted Radical Prostatectomy: A minimally invasive surgical procedure to remove the entire prostate gland and nearby tissues through small incisions.
Active Surveillance: An intensive monitoring protocol for low-risk, slow-growing tumors designed to safely delay or avoid invasive intervention.
Stereotactic Body Radiation Therapy (SBRT): A highly targeted radiation treatment that delivers concentrated, high-dose beams to the tumor site while sparing healthy tissue.
Targeted Radioligand Therapy: An advanced treatment that seeks out and destroys cancer cells throughout the body by targeting the PSMA protein.
PARP Inhibitors: Precision medications used for patients with specific genetic mutations to block cancer cells from repairing their DNA.
Hormone Therapy (ADT): Systemic medications designed to "starve" cancer cells of the hormones they need to grow and spread.
Functional Consultation: Discuss potential impacts on urinary and sexual function with the surgical oncology team to set clear expectations.
Pelvic Floor Strength: Engage in pelvic floor exercises (Kegels) to strengthen the muscles responsible for continence before the procedure.
Clinical Guidelines: Adhere to strict fasting and medication instructions provided by the medical team.
Cardiovascular Assessment: Undergo a heart health evaluation to ensure readiness for a robotic surgical approach.
Recovery Planning: Arrange for a post-operative period that includes assistance with daily tasks during the initial phase of healing.
PSA Blood Test: To measure the current biochemical activity of the prostate gland.
Multiparametric MRI (mpMRI): To provide a detailed "roadmap" for the surgical or radiation oncology team.
Genomic Profiling: Testing the biopsy tissue to determine the exact Gleason score and the presence of specific genetic mutations.
PSMA PET/CT or Bone Scan: Advanced imaging to confirm whether the cancer is localized to the pelvis or has spread to the bones.
Comprehensive Blood Panels: A routine check of your blood count, electrolytes, and kidney function before the administration of anesthesia.
PSA Surveillance: Regular blood tests every few months to ensure PSA levels remain at undetectable or baseline levels.
Metabolic Health: Adoption of a heart-healthy diet and consistent exercise to support overall health and mitigate potential side effects of therapy.
Hormonal Management: Ongoing consultation with specialists to manage bone density, energy levels, and metabolic health.
Follow-up Imaging: Commitment to long-term diagnostic check-ups and scans as scheduled by your oncology team.
Wellness Support: Participation in survivor networks to navigate lifestyle changes and emotional health following treatment.
High Survival Rates: Localized prostate cancer boasts a nearly 100% five-year survival rate through early detection and modern intervention.
Radioligand Technology: Utilizes systemic radiation to treat advanced stages with significantly fewer side effects than traditional chemotherapy.
Nerve-Sparing Robotics: Employs advanced robotic systems that protect the vital nerve bundles responsible for urinary continence and sexual potency.
Genetic Personalization: Offers maintenance plans that target the specific genetic signature of your tumor for more durable results.
Combined Systemic Therapies: Significantly improves outcomes for metastatic patients through protocols that combine hormone, radiation, and targeted therapies.
The cost of Prostate Cancer Surgery in India is generally affordable compared with many other countries, making India a popular destination for international patients seeking quality medical care. The treatment cost depends on factors such as the hospital, doctor's experience, treatment approach, medical condition, hospital stay, diagnostic tests, medicines, and any additional procedures required. For international patients, the starting cost of Prostate Cancer Surgery in India is approximately 1500 USD, although the final price may vary based on individual treatment requirements. Patients are advised to obtain a personalized treatment estimate after medical evaluation.